X

Drug Profile

Colforsin dapropate

Alternative Names: Adehl; Colforsin daropate hydrochloride; NKH 477

Latest Information Update: 27 Aug 2007

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Nippon Kayaku
Class Diterpenes; Heart failure therapies
Mechanism of Action Adenylate cyclase stimulants

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

Highest Development Phases

Marketed Acute heart failure
Discontinued Asthma

Most Recent Events

27 Aug 2007 Discontinued - Preclinical for Asthma in Japan (IV)
28 Nov 2002 A study has been added to the Obstructive Airways Disease therapeutic trials section
03 Mar 2000 Launched for Acute heart failure (Treatment-experienced) in Japan (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com